BRIACELL THERAP (BCTX) vs LianBio Sponsored ADR (LIANY)
BRIACELL THERAP and LianBio Sponsored ADR are both Biotechnology companies. BRIACELL THERAP and LianBio Sponsored ADR are of similar size ($37.2M and $34.2M). LianBio Sponsored ADR trades at the lower P/E: 0.0× against 1.9×. Across the 10 metrics below, LianBio Sponsored ADR leads on 9 and BRIACELL THERAP on 1.
Valuation
Profitability
| Metric | BCTX | LIANY | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (173.55%) | 70.96% | (57.72%) |
| Return on assets | (139.20%) | 66.19% | (49.22%) |
| Return on invested capital | (3,311.00%) | (450.47%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack